⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1868510 | 1.00 | — | — | |
| SCHEMBL1864575 | 1.00 | — | — | |
| SCHEMBL5966226 | 0.98 | POLB (0.36) | — | |
| SCHEMBL20295933 | 0.92 | — | — | |
| SCHEMBL360829 | 0.92 | — | — | |
| SCHEMBL20295697 | 0.92 | — | — | |
| SCHEMBL5966260 | 0.84 | — | — | |
| SCHEMBL5482159 | 0.81 | POLB (0.34) | — | |
| SCHEMBL11384229 | 0.79 | KDM4E (0.34) | — | |
| SCHEMBL11384206 | 0.79 | KDM4E (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200050105-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-02-13 | — | — | US | disclosed |
| US-20190110476-A1 | NOVEL ISOTHIAZOLAMIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-04-18 | — | — | US | disclosed |
| EP-3236752-A2 | NOVEL ISOTHIAZOLAMIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES | Bayer CropScience Aktiengesellschaft (DE) | 2017-11-01 | — | — | EP | disclosed |
| WO-2016102435-A2 | NOVEL ISOTHIAZOLAMIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-06-30 | — | — | WO | disclosed |
| US-7939509-B2 | Partial and full agonists of A1 adenosine receptors | GILEAD SCIENCES, INC. (US) | 2011-05-10 | — | — | US | disclosed |
| CN-102014915-A | Adenosine derivatives as partial and full agonists of A1 adenosine receptors | CV THERAPEUTICS INC | 2011-04-13 | — | — | CN | disclosed |
| CN-101983062-A | ABCA-1 increasing compounds and uses thereof | CV THERAPEUTICS INC | 2011-03-02 | — | — | CN | disclosed |
| EP-2259790-A1 | ABCA-1 ELEVATING COMPOUNDS AND THE USE THEREOF | Gilead Palo Alto, Inc. (US) | 2010-12-15 | — | — | EP | disclosed |
| US-20100210579-A1 | PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS | GILEAD PALO ALTO, INC. (US) | 2010-08-19 | — | — | US | disclosed |
| US-7713946-B2 | Partial and full agonists A1 adenosine receptors | CV THERAPEUTICS, INC. (US) | 2010-05-11 | — | — | US | disclosed |
| WO-2009100326-A1 | ABCA-1 ELEVATING COMPOUNDS AND THE USE THEREOF | CV THERAPEUTICS, INC. (US) | 2009-08-13 | — | — | WO | disclosed |
| US-20090203689-A1 | ABCA-1 ELEVATING COMPOUNDS AND METHODS | CV THERAPEUTICS, INC. | 2009-08-13 | — | — | US | disclosed |
| WO-2008077050-A1 | ADENOSINE DERIVATIVES AS PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS | CV THERAPEUTICS, INC. (US) | 2008-06-26 | — | — | WO | disclosed |
| US-20070185051-A1 | Partial and full agonists of A1 adenosine receptors | GILEAD SCIENCES, INC. | 2007-08-09 | — | — | US | disclosed |
| US-20070066560-A1 | Partial and full agonists of A1 adenosine receptors | ELZEIN ELFATIH | 2007-03-22 | — | — | US | disclosed |
| US-7157440-B2 | Partial and full agonists of A1 adenosine receptors | CV THERAPEUTICS, INC. (US) | 2007-01-02 | — | — | US | disclosed |
| US-6946449-B2 | Partial and full agonists of A1 adenosine receptors | CV THERAPEUTICS, INC. (US) | 2005-09-20 | — | — | US | disclosed |
| US-20050020532-A1 | Partial and full agonists of A1 adenosine receptors | GILEAD PALO ALTO, INC. | 2005-01-27 | — | — | US | disclosed |
| WO-2004007519-A1 | PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS | CV THERAPEUTICS, INC. (US) | 2004-01-22 | — | — | WO | disclosed |
| US-20030050275-A1 | Partial and full agonists of A1 adenosine receptors | GILEAD PALO ALTO, INC. | 2003-03-13 | — | — | US | disclosed |